Alphatec Holdings, Inc.

Alphatec Holdings manufactures and sells medical devices for surgical treatment of spinal disorders across the United States and internationally. The company's product portfolio spans implants, instruments, imaging systems, and biologics used in spine surgery procedures. Its offerings include the Alpha InformatiX platform featuring EOS imaging for full-body diagnostics, the SafeOp Neural InformatiX System for intra-operative neurophysiological monitoring, and Valence, an integrated navigation and robotics system. The company also produces spinal implant systems such as NanoTec and Invictus, access systems including Sigma-ALIF, and various retractor and positioning devices designed for specific surgical approaches.

The biologics segment comprises demineralized bone matrix products under the AlphaGRAFT brand, synthetic bone substitutes like BioCORE, 3D ProFuse osteconductive scaffolds, and amniotic tissue barriers. These products support bone regeneration and graft applications in spinal fusion procedures.

Alphatec operates a sales network of independent agents and direct representatives. The company employs 913 full-time staff and maintains its headquarters in Carlsbad, California. Founded in 1990 and incorporated in Delaware, the company trades on the Nasdaq with a market capitalization of approximately $2.0 billion.